InvestorsHub Logo

Ludo2705

07/14/15 10:05 AM

#19705 RE: starkd748 #19704

For your information, Stev has several strategic provisionnal patents and will start clinical testing by the end of 2015

Fallingknife75

07/14/15 10:18 AM

#19707 RE: starkd748 #19704

Since this is was your first post on STEV's board first of all welcome aboard. However you should do more research into the company and it's plans prior to making such statements.

http://www.otcmarkets.com/stock/STEV/news/Stevia-Corp--Discusses-Partnership-Plans-While-Continuing-to-Implement-a-Broad-Intellectual-Property-and-Commercial-Strategy-Related-to-Cannabis-and-Industrial-Hemp?id=105345&b=y

"To maximize the value of our IP while using minimal resources, we are in discussions to establish one or two early stage clinical trials with the CBD/OTC drug formulations and complete animal safety studies with a minimum goal to receive Investigational New Drug ("IND") approval and then begin recruiting patients for a Phase 1 trial. We fully intend to pursue partnerships with major pharmaceutical and biotech companies."



Good times ahead,

Knife